Roivant Sciences Ltd (ROIV)

04:50 AM

Price Consolidation Hints at Upcoming Move in Roivant Sciences Ltd.Earnings Growth Report & Safe Swing Trade Setups - sundaytimes.kr

04:50 AM

12:47 PM

Roivant plans $500M new share repurchase as brepocitinib data readout nears - msn.com

12:47 PM

Aug 16, 2025

Roivant’s High-Stakes Pipeline Bets On Biotech Breakthroughs - Finimize

Aug 16, 2025

Aug 15, 2025

Roivant Sciences: Vant Model And IMVT-1402 Create A 2025 Catalyst Stack (NASDAQ:ROIV) - Seeking Alpha

Aug 15, 2025

Aug 13, 2025

Roivant Sciences Ltd. Approaches Psychological Resistance Level2025 Big Picture & Weekly Market Pulse Alerts - 선데이타임즈

Aug 13, 2025

Aug 13, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Analysts Just Slashed This Year's Revenue Estimates By 17% - 富途牛牛

Aug 13, 2025

Aug 13, 2025

Roivant Sciences’ (ROIV) Aggressive Buybacks Amid Losses: Commitment to Shareholders or Growth Uncertainty? - simplywall.st

Aug 13, 2025

Aug 12, 2025

Roivant Sciences Earnings Call: Progress Amid Challenges - TipRanks

Aug 12, 2025

Aug 12, 2025

Why Roivant Sciences Stock Bounced Back on Tuesday - Mitrade

Aug 12, 2025

Aug 12, 2025

Roivant Sciences shares rise 2.91% intraday after announcing a $500 million share repurchase program. - AInvest

Aug 12, 2025

Aug 12, 2025

Chairman on Gubra CEO change: Henrik Blou wants to try something different - medwatch.com

Aug 12, 2025

Aug 12, 2025

Leerink Partners raises Roivant Sciences stock price target to $18 on lower share count By Investing.com - Investing.com South Africa

Aug 12, 2025

Aug 12, 2025

Leerink Partners raises Roivant Sciences stock price target to $18 on lower share count - Investing.com Australia

Aug 12, 2025

Aug 12, 2025

Roivant Sciences Q1 2025 Earnings Call Highlights: Strong Cash Position and Share Repurchase Amidst Legal and Market Challenges - AInvest

Aug 12, 2025

Aug 12, 2025

Roivant Sciences Ltd (ROIV) Q1 2025 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada

Aug 12, 2025

Aug 12, 2025

Why Roivant Sciences Ltd. stock attracts strong analyst attentionHyper-Growth Screener - classian.co.kr

Aug 12, 2025

Aug 12, 2025

Roivant Sciences Reports Q1 2025 Financial Results - TipRanks

Aug 12, 2025

Aug 11, 2025

Roivant Reports Financial Results for the First Quarter Ended June 30, 2025, and Provides Business Update - GlobeNewswire

Aug 11, 2025

Aug 11, 2025

Why Roivant Sciences Stock Was Slipping on Monday - Mitrade

Aug 11, 2025

Aug 11, 2025

Roivant Sciences Sees Losses Grow But Investors Hold Steady - Finimize

Aug 11, 2025

Aug 11, 2025

Roivant Sciences Q1 2026 Earnings Call Transcript - MarketBeat

Aug 11, 2025

Aug 11, 2025

Roivant Deepens Its Losses But Keeps Investors On Board - Finimize

Aug 11, 2025

Aug 11, 2025

Roivant Sciences Reports Q1 EPS of 33c, Revenue of $2.17M, and Initiates $1.5B Share Buyback Program - AInvest

Aug 11, 2025

Aug 11, 2025

A Glimpse of Roivant Sciences's Earnings Potential - 富途牛牛

Aug 11, 2025

Aug 11, 2025

Roivant Sciences Ltd. announces an Equity Buyback for $500 million worth of its shares. - MarketScreener

Aug 11, 2025

Aug 11, 2025

Roivant Sciences Completes Equity Buyback Plan with 19.59% of Shares Repurchased - AInvest

Aug 11, 2025

Aug 11, 2025

Tranche Update on Roivant Sciences Ltd.'s Equity Buyback Plan announced on April 2, 2024. - MarketScreener

Aug 11, 2025

Aug 11, 2025

Roivant's Q1 2025 Earnings Call: Unraveling the Contradictions in Brepo's DM Market Positioning and Efficacy Expectations - AInvest

Aug 11, 2025

Aug 11, 2025

Roivant Sciences Ltd. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:ROIV) - Seeking Alpha

Aug 11, 2025

Aug 11, 2025

Roivant Sciences Ltd reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 11, 2025

Aug 11, 2025

Transcript : Roivant Sciences Ltd., Q1 2026 Earnings Call, Aug 11, 2025 - MarketScreener

Aug 11, 2025

Aug 11, 2025

Roivant Sciences Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2025 - MarketScreener

Aug 11, 2025

Aug 11, 2025

Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Aug 11, 2025

Aug 11, 2025

Roivant Sciences earnings missed by $0.08, revenue fell short of estimates - Investing.com South Africa

Aug 11, 2025

Aug 11, 2025

Roivant Sciences Q1 Swings to Loss, Revenue Falls - MarketScreener

Aug 11, 2025

Aug 11, 2025

Biopharma firm Roivant's Q1 revenue declines, net loss widens to $273.9 mln - MarketScreener

Aug 11, 2025

Aug 11, 2025

Roivant Sciences Ltd. (ROIV) Misses Q1 EPS by 8c - StreetInsider

Aug 11, 2025

Aug 11, 2025

Earnings Flash (ROIV) Roivant Sciences Ltd. Reports Q1 Revenue $2.2M, vs. FactSet Est of $7.3M - MarketScreener

Aug 11, 2025

Aug 11, 2025

Earnings Flash (ROIV) Roivant Sciences Posts Fiscal Q1 Net Loss $0.33 a Share, vs. FactSet Est of $0.28 Loss - MarketScreener

Aug 11, 2025

Aug 11, 2025

Will Roivant Sciences Ltd. outperform the marketAI Intraday Market Movement Prediction Tool - Newser

Aug 11, 2025

Aug 11, 2025

Will Roivant Sciences Ltd. see short term momentumStrong Buy Signal Summary with Entry Zone - Newser

Aug 11, 2025

Aug 10, 2025

How high can Roivant Sciences Ltd. stock goDaily Entry Opportunity Forecasting Tool - Newser

Aug 10, 2025

Aug 10, 2025

Roivant Sciences Ltd. Breaks Losing Streak — Is the Trend ReversingTrade Scanner With Buy Zone Alerts Flagged - metal.it

Aug 10, 2025

Aug 09, 2025

Is Roivant Sciences Ltd. stock a good hedge against inflationTechnical Reversal Pattern Summary and Tracker - Newser

Aug 09, 2025

Aug 09, 2025

Roivant Sciences Earnings Expectations: A Closer Look at the Company's Performance and Analyst Sentiments - AInvest

Aug 09, 2025

Aug 09, 2025

Roivant Sciences (ROIV) to Release Earnings on Monday - Defense World

Aug 09, 2025